These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

297 related items for PubMed ID: 16884838

  • 1. CNS prophylaxis in lymphoma: who to target and what therapy to use.
    Hill QA, Owen RG.
    Blood Rev; 2006 Nov; 20(6):319-32. PubMed ID: 16884838
    [Abstract] [Full Text] [Related]

  • 2. Central nervous system recurrence in adult patients with acute lymphoblastic leukemia: frequency and prognosis in 467 patients without cranial irradiation for prophylaxis.
    Sancho JM, Ribera JM, Oriol A, Hernandez-Rivas JM, Rivas C, Bethencourt C, Parody R, Deben G, Bello JL, Feliu E, Programa para el Estudio y Tratamiento de Hemopatias Malignas Group.
    Cancer; 2006 Jun 15; 106(12):2540-6. PubMed ID: 16700036
    [Abstract] [Full Text] [Related]

  • 3. Central nervous system-directed preventative therapy in adults with lymphoma.
    McMillan A.
    Br J Haematol; 2005 Oct 15; 131(1):13-21. PubMed ID: 16173958
    [Abstract] [Full Text] [Related]

  • 4. Methotrexate infusions as central nervous system prophylaxis in children with acute lymphocytic leukemia: the Norwegian experience.
    Moe PJ, Holen A, Nygaard R, Glomstein A, Madsen B, Hellebostad M, Stokland T, Wefring KW, Steen-Johnsen J, Nielsen B, Hapnes C, Børsting S.
    Pediatr Hematol Oncol; 2003 Oct 15; 20(3):187-200. PubMed ID: 12637215
    [Abstract] [Full Text] [Related]

  • 5. Central nervous system dissemination in immunocompetent patients with aggressive lymphomas: incidence, risk factors and therapeutic options.
    Ferreri AJ, Assanelli A, Crocchiolo R, Ciceri F.
    Hematol Oncol; 2009 Jun 15; 27(2):61-70. PubMed ID: 19247977
    [Abstract] [Full Text] [Related]

  • 6. CNS prophylaxis in diffuse large B-cell lymphoma: if, when, how and for whom?
    Siegal T, Goldschmidt N.
    Blood Rev; 2012 May 15; 26(3):97-106. PubMed ID: 22244544
    [Abstract] [Full Text] [Related]

  • 7. Should intra-cerebrospinal fluid prophylaxis be part of initial therapy for patients with non-Hodgkin lymphoma: what we know, and how we can find out more.
    Herrlinger U, Glantz M, Schlegel U, Gisselbrecht C, Cavalli F.
    Semin Oncol; 2009 Aug 15; 36(4 Suppl 2):S25-34. PubMed ID: 19660681
    [Abstract] [Full Text] [Related]

  • 8. Risk factors for poor treatment outcome and central nervous system relapse in diffuse large B-cell lymphoma with bone marrow involvement.
    Lee KW, Yi J, Choi IS, Kim JH, Bang SM, Kim DW, Im SA, Kim TY, Yoon SS, Lee JS, Bang YJ, Park S, Kim BK, Cho HI, Heo DS.
    Ann Hematol; 2009 Sep 15; 88(9):829-38. PubMed ID: 19172274
    [Abstract] [Full Text] [Related]

  • 9. Prevention of CNS relapse in diffuse large B-cell lymphoma.
    Kridel R, Dietrich PY.
    Lancet Oncol; 2011 Dec 15; 12(13):1258-66. PubMed ID: 21933751
    [Abstract] [Full Text] [Related]

  • 10. Central nervous system prophylaxis in diffuse large B-cell lymphoma.
    Zahid MF, Khan N, Hashmi SK, Kizilbash SH, Barta SK.
    Eur J Haematol; 2016 Aug 15; 97(2):108-20. PubMed ID: 27096423
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Secondary central nervous system lymphoma: risk factors and prophylaxis.
    Montoto S, Lister TA.
    Hematol Oncol Clin North Am; 2005 Aug 15; 19(4):751-63, viii. PubMed ID: 16083835
    [Abstract] [Full Text] [Related]

  • 13. The risk of CNS involvement in aggressive lymphomas in the rituximab era.
    Benevolo G, Chiappella A, Vitolo U.
    Expert Rev Hematol; 2013 Dec 15; 6(6):643-52. PubMed ID: 24168678
    [Abstract] [Full Text] [Related]

  • 14. Use of intrathecal prophylaxis in allogeneic haematopoietic stem cell transplantation for malignant blood diseases: a survey of the European Group for Blood and Marrow Transplantation (EBMT).
    Ruutu T, Corradini P, Gratwohl A, Holler E, Apperley J, Dini G, Rocha V, Schmitz N, Socié G, Niederwieser D.
    Bone Marrow Transplant; 2005 Jan 15; 35(2):121-4. PubMed ID: 15543201
    [Abstract] [Full Text] [Related]

  • 15. Prevention of central nervous system relapses in diffuse large B-cell lymphoma: which patients and how?
    Korfel A.
    Curr Opin Oncol; 2011 Sep 15; 23(5):436-40. PubMed ID: 21760506
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Secondary lymphomas of the central nervous system: risk, prophylaxis and treatment.
    van Besien K, Gisselbrecht C, Pfreundschuh M, Zucca E.
    Leuk Lymphoma; 2008 Sep 15; 49 Suppl 1():52-8. PubMed ID: 18821433
    [Abstract] [Full Text] [Related]

  • 20. Consideration of aggressive therapeutic strategies for primary testicular lymphoma.
    Park BB, Kim JG, Sohn SK, Kang HJ, Lee SS, Eom HS, Kwon HC, Oh SY, Kang JH, Oh SJ, Shin HJ, Suh C, Kim JH, Kim HY, Kim K, Ryoo BY, Kim WS.
    Am J Hematol; 2007 Sep 15; 82(9):840-5. PubMed ID: 17563078
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.